Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Cliff Driving 2013

Click to download the PDF to view the full issue Battered by the expiration of exclusivity of blockbuster products, Sanofi is driven to grow other areas of its business. The patent cliff continued to take its toll on Sanofi during 2012 and first-half 2013. But executives believe that the worst is probably over and they […]

Read More »

Steady As She Goes 2013

Click to download the PDF to view the full issue Roche once again enjoyed growth in 2012 despite market difficulties, and the company continues its winning strategy of developing drugs for unmet needs and companion diagnostics. Despite increasing cost pressures in many markets, 2012 was a positive year for Roche, in which the company posted […]

Read More »

Refocused On Success 2013

Click to download the PDF to view the full issue As Pfizer continues to be weighed down by Lipitor’s patent expiration, the company has sold off its animal health business and is moving to internally split its commercial operations into three business segments. At Pfizer, there is a new slogan and a new attitude. As […]

Read More »

Q&A with Lars Rebien Sorensen 2013

Click to download the PDF to view the full issue Med Ad News: What do you feel are the major strategic and marketplace challenges today for a company such as Novo Nordisk, and how is the company meeting those challenges? LS: One of the challenges is one we share with all of the pharmaceutical companies, […]

Read More »

A sweet spot to be in, 2013

Click to download the PDF to view the full issue For Novo Nordisk in 2012, laser-focused strategy paid off once again with double-digit growth, despite the continuing difficulties in the world economy. Med Ad News’ Company of the Year had sales growth of almost 18 percent in 2012, and for the first half of 2013, […]

Read More »

Strategic Priority Progress 2013

Click to download the PDF to view the full issue A new wave of innovation, productivity, and growth is helping Novartis move past significant patent expirations into the next phase of growth for the company. Novartis capitalized on strong momentum from innovation, growth and productivity throughout 2012 in an effort to offset patent expirations to […]

Read More »

Long Term Strategy 2013

Click to download the PDF to view the full issue Amgen is concentrating on the product pipeline, international expansion, and its entry into the biosimilar market to drive company growth during the years ahead. Amgen executives cited 2012 as an exceptional year for the company. Amgen generated 11 percent revenue growth, 2 percent adjusted earnings […]

Read More »

First Steps 2013

Click to download the PDF to view the full issue The newborn AbbVie came into being at the beginning of 2013, bringing with it the world’s best-selling prescription product and the rest of the legacy Abbott Labs biopharmaceuticals portfolio. The legacy Abbott Laboratories had two major goals in 2012, one usual and one unusual. While […]

Read More »

Fighting Back 2013

Click to download the PDF to view the full issue Although the market-exclusivity loss of Singulair has hurt the company’s top line of late, Merck has plenty of high-potential products on the market and in the pipeline with which to recover. As one of the world’s largest pharmaceutical companies, Merck has more than enough wherewithal […]

Read More »

4 women, 4 paths, 1 goal

Click to download the PDF to view the full issue Although the four women interviewed for this article – Anna Protopapas, president and CEO of Millennium Pharmaceuticals; Jill DeSimone, senior VP and general manager of Teva Global Women’s Health; Dr. Joanna Horobin, chief medical officer of Verastem; and Dr. Cynthia Verst, head of the global […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom